Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
alacizumab pegol vascular endothelial growth factor receptor 2 NA Successful target TTD , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.46 phase 2 antagonist
alacizumab pegol vascular endothelial growth factor receptor 2 NA Successful target TTD , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 2 unknown
click here to return to the previous page